Enthral.ai’s platform integrates AI-driven capabilities with compliance-first architecture, enabling automated training workflows
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
Emcure to distribute Roche's kidney transplant and anemia drugs in India
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
To support this launch, ImmunityBio has established a wholly owned subsidiary in Saudi Arabia
Subscribe To Our Newsletter & Stay Updated
